INLA methods identified hypervariable CpG sites faster than MCMC in healthy individuals
This cohort study included 158 healthy individuals within the MAMELI cohort setting. The primary objective was the identification of hypervariable CpG sites. The comparator involved MCMC-based methods. The study also assessed computational runtime comparison and concordance with MCMC-based methods as secondary outcomes.
Hypervariable CpG sites were identified using the INLA approach. Computational runtime was shorter by orders of magnitude when using INLA versus MCMC. Concordance between the two methods was reported as concordant. Specific absolute numbers, p-values, or confidence intervals were not reported for these outcomes.
Safety data, adverse events, and tolerability were not reported. Follow-up duration was not reported. The study phase was not reported. Funding or conflicts of interest were not reported. Practice relevance was not reported. Limitations were not explicitly listed in the provided data. Given the observational nature of the cohort and missing details, clinical application should be restrained.